文献速递腹部儿科影像MR

肝胆特异性MRI对比剂:儿童局灶性肝脏病变的模式识别方法

Hepatobiliary MRI Contrast Agents: Pattern Recognition Approach to Pediatric Focal Hepatic Lesions.
PubMed 文献 · AJR Am J Roentgenol · 2020-03-17

本文旨在综述现有肝胆特异性对比剂、讨论优化儿童肝胆期MRI的技术,并回顾多种儿童肝脏病变的影像特征,重点评估肝胆特异性对比剂的应用。结论认为MRI是全面评估儿童局灶性肝脏病变的首选影像方法,钆基肝胆特异性对比剂成像可提供有益信息。

要点

  • MRI是儿童局灶性肝脏病变全面评估的首选影像方法。
  • 钆基肝胆特异性对比剂成像可提供儿童多种局灶性肝脏病变的有益信息。
  • 需掌握儿童肝胆期MRI优化技术以发挥对比剂诊断价值。

核心结论

  • MRI是儿童局灶性肝脏病变全面评估的首选影像方法,钆基肝胆特异性对比剂成像可提供有益信息。

研究设计与样本

  • 综述,旨在回顾现有肝胆特异性对比剂、讨论优化儿童肝脏MRI的技术,并回顾多种儿童肝脏病变的影像特征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purposes of this article are to review currently available hepatobiliary contrast agents, discuss techniques for optimization of pediatric liver MRI with hepatobiliary contrast agents, and review the imaging features of several pediatric hepatic lesions, focusing on their assessment with hepatobiliary contrast agents. CONCLUSION. MRI is the preferred imaging modality for complete assessment of focal liver lesions in the pediatric population. Imaging with gadolinium-based hepatobiliary contrast agents yields beneficial information about many focal liver lesions encountered in pediatric patients.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Schooler GR, Hull NC, Lee EY, et al. Hepatobiliary MRI Contrast Agents: Pattern Recognition Approach to Pediatric Focal Hepatic Lesions. AJR Am J Roentgenol. 2020. PMID: 32182093. doi:10.2214/AJR.19.22239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。